Submit Release
EIN News
Thursday, June 2, 2016
Get RSS Feed Submit Release
Menu > All News Topics ; Press Releases by Industry Channel
Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars
[Posted 06/02/2016]
AUDIENCE: Internal Medicine, Pain Management, Neurology, Pharmacy
ISSUE: FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic transdermal system) patch for migraine headaches. Since marketing of the Zecuity patch began in September 2015, a large number of patients have reported they experienced burns or scars on the skin where the patch was worn. The reports included descriptions of severe redness, pain, skin discoloration, blistering, and cracked skin. As a result, FDA is investigating these serious adverse events to determine whether future regulatory action is needed, and will update the public with new information when the FDA review is complete.
BACKGROUND: The Zecuity patch contains the active ingredient sumatriptan, a prescription medicine used to treat acute migraine headaches in adults. The patch delivery system is designed to deliver a dose of medicine by way of a single-use, battery-powered patch that is wrapped around the upper arm or thigh. It should remain in place for no longer than four hours.
RECOMMENDATION: Patients who experience moderate to severe pain at the Zecuity patch site should immediately remove it to avoid possible burns or scarring, regardless of how long the patch has been worn, and contact your health care professional. Do not bathe, shower, or swim while wearing the patch. Read the Patient Information leaflet and the Instructions for Use section in the drug label, and talk with your health care professional if you have any questions or concerns.
Health care professionals should advise patients who complain of moderate to severe pain at the application site to remove the Zecuity patch immediately. Consider a different formulation of sumatriptan or switch these patients to an alternative migraine medicine. Evaluate patients and the application site as needed.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
Complete and submit the report Online: www.fda.gov/MedWatch/report
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
[06/02/2016 - Drug Safety Communication - FDA]
Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals
Submit your press release
articles: 329,116,643
readers: 3,929,694
Got News to Share? Click here.
EIN Presswire
Submit a press release · See all
Newsfeed Maker
NewsPlugin
Email News Alerts
Datamine from our index of 250 million articles – updated in real time – and have headlines emailed to you. An affordable clipping service with advanced easy-to-use tools to customize your topics.
Press Releases
Do you have news to share? Plug your news into the daily news cycle with EIN Presswire. Your news IS news. Our users are monitoring specific topics – they can't go to thousands of websites – so they rely on EIN Newsdesk to sort and filter news which matches their specific interests. Match it up to those who care.
Publications
Access dozens of industry publications managed by EIN News. Get news relevant to your Industry or Profession. Our news is aggregated from thousands of sources and organized for you. Find events and conferences that match your interest and read press releases before your competition.
Events & Conferences
EIN Newsdesk is a “Go-To” destination for journalists and other professionals world-wide who are deeply involved in very specific topics. Our vertical niche publications reach industry leaders and decision makers who meet at conferences. Upload your event today.
RSS News Feeds
Stream live news headlines to your website, blog or applications. Get RSS feeds on a variety of news topics maintained by our editors or create your custom newsfeeds on any topic. You'll get a truly customized output.
News Topics
All News Topics
News by Country
News by U.S. State
Newsletters
Create Newsletter
Search Newsletters
Browse Newsletters
Press Releases
Submit Release
Browse Featured Releases
Browse All Releases
Events & Conferences
Create Event
Search Events
Browse Events
RSS Feeds
Create RSS Feed
Search RSS Feeds
Browse RSS Feeds
Other Services
World Media Directory
NewsPlugin for Wordpress
Blog Op/Ed
Questions?
About EIN Newsdesk
How-to Videos
User Agreement
Privacy Policy
Contact
Login
Sign Up
EIN Newsdesk & EIN Presswire (a press release distribution service)
Follow us on Facebook & Twitter and connect with us on LinkedIn
IPD Group, Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About
© 1995-2016 IPD Group, Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement
=
